Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population.

Doran S, Mysore M, Kassaian SE, Kotloff E, Kamangar F, Emadi A, Apata J, Barr B. Hypertension, smoking, and preexistence of multiple cardiac risk factors correlate with carfilzomib-induced cardiovascular adverse events in a racially diverse population. Front Cardiovasc Med. 2023; 10:1129943.

View in: PubMed

authors with profiles

Farin Kamangar
Jummai Apata

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support